Food and Drug Administration (FDA) Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, despite a steady pressure campaign from abortion opponents.

Speaking at the Semafor World Economy Summit on Thursday, Makary said he would reconsider if there is new data that would suggest a safety issue.

The Food and Drug Administration approved mifepristone in 2000 to terminate pregnancies up to seven weeks. The drug is taken in conjunction with misoprostol in a two-medication regimen that constitutes the majority of abortions in the country.

Scientists and top medical groups contend it has been studied extensively and is proven to be safe. It’s been used by millions of women with minimal side effects.

A group of anti-abortion physicians and medical associations previously sued to impose additional restrictions on........

© The Hill